- EE407 Budget Impact Analysis of Paliperidone Palmitate in Chronic Schizophrenia in the Mental Health Secretariat-Egyptian Ministry of Health. Elsisi, G et al. Value in Health, Volume 27, Issue 12, S135 November 17-20 2024, Barcelona, Spain
- EE186 Cost-Minimization Analysis for Subcutaneous Daratumumab in the Treatment of Newly Diagnosed Multiple Myeloma in Qatar Hamad, A et al. Value in Health, Volume 27, Issue 12, S90
November 17-20 2024, Barcelona, Spain
- EE515 Cost-Effectiveness Analysis of Sacubitril/Valsartan in Heart Failure Patients in Egypt
Khalil, A et al. Value in Health, Volume 27, Issue 12, S157
November 17-20 2024, Barcelona, Spain
- EE624 Budget Impact of Intravenous Eptinezumab in the Prevention of Chronic Migraine Patients in United Arab Emirates Elattar, M et al. Value in Health, Volume 27, Issue 12, S178
November 17-20 2024, Barcelona, Spain
- RWD131 Budget Impact Analysis of Emicizumab in Hemophilia A Pediatric Patients From Payer Perspective in Egypt Awadallah, M. et al. Value in Health, Volume 27, Issue 12, S598 – S599
November 17-20 2024, Barcelona, Spain
- Gihan Hamdy Elsisi, Mary Gergis, Amal Samir, Ahmed Elagamy, Ahmed Seyam, Mariam Eldebeiky, Randa
Eldessuoki. HTA341, Egyptian Guidelines for Pharmacoeconomic Evaluations: toward
Standardization of Drug Reimbursement Applications. November 12-15 2023, Copenhagen, Denmark
https://www.ispor.org/docs/default-source/euro2023/guidelines-poster128687-pdf.pdf?sfvrsn=975e1b81_0
- G. Elsisi, M. Elattar, N. Eldesouky, EE260 Cost-Effectiveness Analysis of Daratumumab Triplet Therapy Vs Carfilzomib Duplet Therapy in Patients with Relapsed or Refractory Multiple Myeloma in Egypt from Payer Perspective, Value in Health, Volume 26, Issue 12, Supplement, 2023,Page S101,ISSN 1098- 3015, https://doi.org/10.1016/j.jval.2023.09.527
- M. Elattar, A.H. Abdelaziz, B. Eshaak, E. Shash, H. El-Zawahery, H. Tawfik, I. Saad, K.A.A. Kamal, M. Elgazzar, M.S. Alkady, S. Shehata, T. Hashem, Y. Nada, G. Elsisi, CO92 Clinician-Reported Outcome Measure for Palonosetron Versus Standard of Care in Chemotherapy-Induced Nausea and Vomiting in Egypt, Value in Health, Volume 26, Issue 12, Supplement, 2023, Page S31, ISSN 1098-3015, https://doi.org/10.1016/j.jval.2023.09.164
- Economic evaluation of generic Tacrolimus and the innovator in renal transplant recipients in Egypt, EE288: Poster presentation, 8 November 2022, Vienna, Austria. https://www.valueinhealthjournal.com/article/S1098-3015(22)02739-5/fulltext
- Hamouda M, Awad H, Elsisi G. (2022) Budget Impact Analysis of an Alternative Meningococcal Conjugate Vaccine for High-Risk Infants in Egypt. Value in Health. Poster presentation: POSC121
- Moussa M….Elsisi G. A Cost effectiveness study of percutaneous coronary intervention versus CABG in Egypt for patient with previously untreated three vessel or left main CAD: Markov Model (2021) A Cost effectiveness study of percutaneous coronary intervention versus CABG in Egypt for patient with previously untreated three vessel or left main CAD: Markov Model. Value in Health · Poster presentation: PCV13
- Elkony M, Elsisi G. Cost Minimization Analysis of Secukinumab versus Infliximab in Egyptian Patients with Ankylosing Spondylitis from Health Care Provider Perspective. Poster presentation PMS59 at ISPOR 21th Annual European Congress, November 2018; Barcelona, Spain.
- Assal R, Elsisi G. Cost Effectiveness Analysis of Pegylated Liposomal and Nonliposomal Doxorubicin Formulations for the First Line Treatment of Metastatic Breast Cancer from Patient Perspective in Egypt. Poster presentation PCN160 at ISPOR 21th Annual European Congress, November 2018; Barcelona, Spain.
- Elsisi G, Emad S, Hamed A. Are There Enough Regulations to Combat the Poor Quality Povidone-Iodine in Egypt. Poster presentation PHP341 at ISPOR 21th Annual European Congress, November 2018; Barcelona, Spain.
- Abu Rawash A, Elsisi G. Cost-Effectiveness Analysis of Everolimus Plus Exemestane versus Exemestane Alone For Treatment of Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer from Private Sector Prespective in Egypt. Poster presentation PCN154 at ISPOR 21th Annual European Congress, November 2018; Barcelona, Spain.
- Fouad S, Elsisi G. Cost-Utility of Switching to Fingolimod in Treating Patients with Relapsing-Remitting Multiple Sclerosis: A Health Insurance Perspective. Poster presentation PND75 at ISPOR 21th Annual European Congress, November 2018; Barcelona, Spain.
- Elwahsh N, Elsisi G. Cost Effectiveness of Voriconazole versus Conventional Amphotericin B for Invasive Aspergillosis in Immunocompromised Egyptian Patients Decision-Analytical Model. Poster presentation PIN58 at ISPOR 21th Annual European Congress, November 2018; Barcelona, Spain.
- Elshafie Z, Elsisi G, Botros A. Cost-Minimization Analyses Of Biological Therapies In The Treatment Of Rheumatoid Arthritis From The Egyptian Healthcare System Perspective. Poster presentation PMS53 at ISPOR 20th Annual European Congress, November 2017; Scottish Event Campus in Glasgow, Scotland.
- Elshafie Z, Elsisi G. Economic Evaluation Of Exemestane Versus Tamoxifen In Post-Menopausal Women With Early Breast Cancer From The Egyptian Health Care System Perspective poster presentation PCN157 at ISPOR 20th Annual European Congress, November 2017; Scottish Event Campus in Glasgow, Scotland.
- Elkony M. Elsisi G. Cost Effectiveness Analysis Of Sorafenib Versus Best Supportive Care In Patients With Advanced Hepatocellular Carcinoma From Health Care System Perspective In Egypt. Poster presentation PCN152 at ISPOR 20th Annual European Congress, November 2017; Scottish Event Campus in Glasgow, Scotland.
- Griffin A, Elsisi G, Ragab S, Ziada R, Abushadi R, Safori S, Khatabi N, Atef M, Ashraf, R. Setting Recommendations For Good Practice Of Health Technology Assessment In The Egyptian Ministry Of Health. Poster Presentation PHP326 at ISPOR 19th Annual European Congress October 2016; Austria Center Vienna, Vienna, Austria.
- Abdullah H, ElSisi GH. Cost-Effectiveness Analysis Of Fidaxomicin Versus Oral Vancomycin For The Treatment Of Clostridium Difficile Infection In Egypt Poster Presentation PGI22 at ISPOR 19th Annual European Congress October 2016; Austria Center Vienna, Vienna, Austria.
- Abu Rawash A, Eldessouki R, ElSisi GH. Cost Effectiveness Analysis Of Nilotinib Versus Imatinib In Newly Diagnosed Chronic Myeloid Leukemia From The Health Insurance Perspective In Egypt. Poster Presentation PCN151 at ISPOR 19th Annual European Congress October 2016; Austria Center Vienna, Vienna, Austria.
- Fahim M, Asl R, Mamdouh M, ElSisi GH. Cost Minimization Analysis of Bevacizumab Versus Cetuximab And Panitumumab In The Management of Colorectal Cancer From Patient Perspective In Egypt. Poster Presentation PCN166 at ISPOR 19th Annual European Congress October 2016; Austria Center Vienna, Vienna, Austria.
- Fouad S, ElSisi GH. Cost Effectiveness of Darbepoetin Alfa Versus Epoetin Alfa in The Management of Anemic Patients with Chronic Kidney disease: the Health insurance Perspective. Poster Presentation PSY79 at ISPOR 19th Annual European Congress October 2016; Austria Center Vienna, Vienna, Austria.
- Mohamed M, ElSisi GH, Elmazar MM, Taha AS, Awad BF, Elhamamsy MH. Cost Effectivess Analysis For Combination Of Aspirin And Warfarin Versus Warfarin Alone In Patients With Heart Valve Prosthesis. Poster Presentation PCV30 at ISPOR 7th Asia-Pacific Conference September 2016; Suntec Singapore Convention & Exhibition Center, Singapore.
- Ragab S, ElSisi GH, Abo Shady R, Hassan R, Abaza S, Abbas Y, Shaheen M, Kalo Z. Challenges That Face The Applicability Of Multi-Indication Pricing For Innovative Products In Egypt. Poster Presentation PHP205 at ISPOR 21st Annual International Meeting, Washington, DC, USA.
- Ragab S, ElSisi GH, Abo Shady R, Hassan R, Abaza S, Abbas Y, Shaheen M, Kalo Z, Diaa M. Pricing Policy For Pharmaceuticals In Egypt: Challenges And Opportunities. Poster Presentation PHP51 at ISPOR 18th Annual European congress, Milan, Italy.
- Elmansy H, Metry A, Eldessouki R, ElSisi GH. Cost-Effectiveness of Zoledronic Acid Versus Alendronic Acid In The Treatment of Osteoporosis In Postmenopausal Egyptian Patients: Decision Analysis. Poster Presentation PMS71 at ISPOR 18th Annual European congress, Milan, Italy.
- ElSisi GH, Abdullah H, Elmansy H. Economic Evaluation Of Lidocaine/ Tetracaine Patch Versus Lidocaine/ Prilocaine Cream For Topical Anaesthesia Before Vascular Access In Egypt. Poster Presentation PSY59 at ISPOR 18th Annual European congress, Milan, Italy.
- ElSisi GH, Said E, Elmahdawy MD. Budget Impact Analysis of Everolimus Plus Exemestane Versus Gemcitabine Plus Paclitaxel And Capecitabine Plus Docetaxel In Metastatic Breast Cancer Patients In Egypt. Poster Presentation PCN49 at ISPOR 17th Annual European congress, Amsterdam, The Netherlands.
- Helal M, ElSisi GH. Cost-Effectiveness of Aprepitant In Egyptian Patients Receiving Highly Emetogenic Therapy From The Third Party Payer Perspective. Poster Presentation PCN114 at ISPOR 17th Annual European congress, Amsterdam, The Netherlands.
- ElSisi GH, Said E, Abo Taleb AM. Economic Evaluation of Lapatinib in HER-2-Positive Metastatic Breast Cancer Patients in Egypt. Poster Presentation PCN159 at ISPOR 17th Annual European congress, Amsterdam, The Netherlands.
- Metry AB, ElSisi GH, Abou Rawash AS, Abo Taleb A. Cost Minimization Analysis Of U100 Insulin And U40 Insulin In Egyptian Diabetic Patients. Poster Presentation PDB28 at ISPOR 6th Asia-Pacific Conference September 2014; Beijing, China.
- Metry AB, ElSisi GH, Abou Rawash AS, Eldessouki R. Budget Impact Analysis Of U100 Insulin In Egyptian Diabetic Patients. Poster Presentation PDB14 at ISPOR 6th Asia-Pacific Conference September 2014; Beijing, China.
- Elsisi GH, Hassouna A, Abo Taleb AM, Elmahdawy MD. Cost-effectiveness Of Pazopanib Versus Sunitinib In Egyptian Patients With Metastatic Renal Cell Carcinoma From The Health Insurance Perspective: A Markov Model. Poster Presentation PCN131 at ISPOR 19th Annual International Meeting 31 May – 4 June 2014; Montreal, Canada.
- Elsisi GH, Ragab S, Ashraf R, Elmahdawy M. Cost-Effectiveness of Drug-Eluting Stents versus Bare Metal Stents in Egyptian Diabetic Patients. Poster Presentation PCV108 at ISPOR 16th Annual European Congress 2-6 November 2013; Dublin, Ireland.
- Elsisi GH, Elmahdawy MD, Abaza S, Elshalakani A. Cost-Effectiveness Of Sapropterin Versus Phenylalanine Free Diet In Patients With Phenylketonuria In Egypt. Poster Presentation PSY45 at ISPOR 16th Annual European Congress 2-6 November 2013; Dublin, Ireland.
- ElSisi G, Botros A & Sharaf Eldeen M. Limitations Of Egyptian Current Pricing System, Poster Presentation Pcase2 at ISPOR 15th Annual European Congress 3-7 November 2012; Berlin, Germany.
- Soliman AM, ElSisi G, Diaa M & Abdulhalim AM. The Status of Pharmacoeconomic Education In Egyptian Schools Of Pharmacy: An Exploratory Analysis.Value In Health 2012, Vol. 15, No.4. Poster Presentation PHP72 at ISPOR 17th Annual International Meeting Washington, DC, USA.
- Elsisi GH, Hassouna A, Abo Taleb AM, Elmahdawy MD. Cost-effectiveness Of Pazopanib Versus Sunitinib In Egyptian Patients With Metastatic Renal Cell Carcinoma From The Health Insurance Perspective: A Markov Model. Poster Presentation PCN131 at ISPOR 19th Annual International Meeting 31 May – 4 June 2014; Montreal, Canada.
- Elsisi GH, Ragab S, Ashraf R, Elmahdawy M. Cost-Effectiveness of Drug-Eluting Stents versus Bare Metal Stents in Egyptian Diabetic Patients. Poster Presentation PCV108 at ISPOR 16th Annual European Congress 2-6 November 2013; Dublin, Ireland.
- Elsisi GH, Elmahdawy MD, Abaza S, Elshalakani A. Cost-Effectiveness Of Sapropterin Versus Phenylalanine Free Diet In Patients With Phenylketonuria In Egypt. Poster Presentation PSY45 at ISPOR 16th Annual European Congress 2-6 November 2013; Dublin, Ireland.
- ElSisi G, Botros A & Sharaf Eldeen M. Limitations of Egyptian Current Pricing System. Poster Presentation Pcase2 at ISPOR 15th Annual European Congress 3-7 November 2012; Berlin, Germany.
- Soliman AM, ElSisi G, Diaa M & Abdulhalim AM. The Status of Pharmacoeconomic Education In Egyptian Schools Of Pharmacy: An Exploratory Analysis.Value In Health 2012, Vol. 15, No.4. Poster Presentation PHP72 at ISPOR 17th Annual International Meeting Washington, DC, USA.
- Elkony M, Elsisi G. Cost Minimization Analysis of Secukinumab versus Adalimumab, Certolizumab Pegol, Etanercept, Golimumab, and Infliximab In Egyptian Patients with Ankylosing Spondylitis From Private Sector Perspective. Poster presentation PMS61 at ISPOR 21th Annual European Congress, November 2018; Barcelona, Spain.
